BNP Paribas Financial Markets’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $168K | Sell |
2,451
-1,493
| -38% | -$101K | ﹤0.01% | 4311 |
|
|
2026
Q1 | $296K | Buy |
3,944
+583
| +17% | +$47.8K | ﹤0.01% | 3870 |
|
|
2025
Q4 | $262K | Buy |
3,361
+198
| +6% | +$16.1K | ﹤0.01% | 3932 |
|
|
2025
Q3 | $269K | Sell |
3,163
-253
| -7% | -$20.3K | ﹤0.01% | 3870 |
|
|
2025
Q2 | $267K | Sell |
3,416
-267
| -7% | -$19.7K | ﹤0.01% | 3666 |
|
|
2025
Q1 | $267K | Sell |
3,683
-12,320
| -77% | -$1.03M | ﹤0.01% | 3550 |
|
|
2024
Q4 | $1.42M | Sell |
16,003
-839
| -5% | -$74.8K | ﹤0.01% | 2596 |
|
|
2024
Q3 | $1.43M | Buy |
16,842
+12,445
| +283% | +$1.1M | ﹤0.01% | 2263 |
|
|
2024
Q2 | $406K | Sell |
4,397
-3,440
| -44% | -$348K | ﹤0.01% | 2769 |
|
|
2024
Q1 | $885K | Buy |
7,837
+502
| +7% | +$50.1K | ﹤0.01% | 2567 |
|
|
2023
Q4 | $683K | Sell |
7,335
-2,209
| -23% | -$194K | ﹤0.01% | 2628 |
|
|
2023
Q3 | $875K | Buy |
9,544
+6,036
| +172% | +$648K | ﹤0.01% | 2407 |
|
|
2023
Q2 | $426K | Sell |
3,508
-1,980
| -36% | -$213K | ﹤0.01% | 2666 |
|
|
2023
Q1 | $537K | Buy |
5,488
+3,497
| +176% | +$334K | ﹤0.01% | 2694 |
|
|
2022
Q4 | $161K | Sell |
1,991
-3,074
| -61% | -$258K | ﹤0.01% | 3078 |
|
|
2022
Q3 | $385K | Buy |
5,065
+771
| +18% | +$74.1K | ﹤0.01% | 3152 |
|
|
2022
Q2 | $469K | Buy |
4,294
+983
| +30% | +$104K | ﹤0.01% | 2694 |
|
|
2022
Q1 | $329K | Sell |
3,311
-4,337
| -57% | -$414K | ﹤0.01% | 2955 |
|
|
2021
Q4 | $731K | Sell |
7,648
-4,780
| -38% | -$479K | ﹤0.01% | 2797 |
|
|
2021
Q3 | $1.37M | Buy |
12,428
+7,863
| +172% | +$896K | ﹤0.01% | 2158 |
|
|
2021
Q2 | $529K | Buy |
4,565
+2,082
| +84% | +$239K | ﹤0.01% | 2503 |
|
|
2021
Q1 | $258K | Sell |
2,483
-101
| -4% | -$12.6K | ﹤0.01% | 2917 |
|
|
2020
Q4 | $311K | Sell |
2,584
-656
| -20% | -$66.2K | ﹤0.01% | 2688 |
|
|
2020
Q3 | $281K | Buy |
3,240
+2,497
| +336% | +$215K | ﹤0.01% | 2558 |
|
|
2020
Q2 | $60.2K | Sell |
743
-4,280
| -85% | -$312K | ﹤0.01% | 2961 |
|
|
2020
Q1 | $347K | Buy |
5,023
+1,723
| +52% | +$182K | ﹤0.01% | 2558 |
|
|
2019
Q4 | $377K | Buy |
3,300
+1,307
| +66% | +$163K | ﹤0.01% | 2638 |
|
|
2019
Q3 | $260K | Buy |
1,993
+378
| +23% | +$49.2K | ﹤0.01% | 2598 |
|
|
2019
Q2 | $198K | Sell |
1,615
-979
| -38% | -$112K | ﹤0.01% | 2635 |
|
|
2019
Q1 | $272K | Buy |
2,594
+2,438
| +1,563% | +$262K | ﹤0.01% | 2501 |
|
|
2018
Q4 | $16K | Sell |
156
-258
| -62% | -$28.6K | ﹤0.01% | 3177 |
|
|
2018
Q3 | $49.1K | Sell |
414
-1,138
| -73% | -$129K | ﹤0.01% | 3048 |
|
|
2018
Q2 | $149K | Sell |
1,552
-2,420
| -61% | -$224K | ﹤0.01% | 2583 |
|
|
2018
Q1 | $323K | Sell |
3,972
-1,149
| -22% | -$89K | ﹤0.01% | 2494 |
|
|
2017
Q4 | $370K | Sell |
5,121
-1,331
| -21% | -$90.8K | ﹤0.01% | 2654 |
|
|
2017
Q3 | $396K | Buy |
6,452
+2,346
| +57% | +$143K | ﹤0.01% | 2113 |
|
|
2017
Q2 | $248K | Buy |
4,106
+1,640
| +67% | +$105K | ﹤0.01% | 2311 |
|
|
2017
Q1 | $161K | Sell |
2,466
-163
| -6% | -$11.6K | ﹤0.01% | 2315 |
|
|
2016
Q4 | $185K | Buy |
2,629
+936
| +55% | +$59.5K | ﹤0.01% | 2250 |
|
|
2016
Q3 | $106K | Sell |
1,693
-2,193
| -56% | -$135K | ﹤0.01% | 2075 |
|
|
2016
Q2 | $234K | Buy |
3,886
+2,057
| +112% | +$113K | ﹤0.01% | 1839 |
|
|
2016
Q1 | $91K | Buy |
1,829
+587
| +47% | +$29.2K | ﹤0.01% | 1815 |
|
|
2015
Q4 | $66.7K | Sell |
1,242
-1,321
| -52% | -$66.2K | ﹤0.01% | 2130 |
|
|
2015
Q3 | $115K | Buy |
2,563
+1,531
| +148% | +$76.3K | ﹤0.01% | 2300 |
|
|
2015
Q2 | $56.5K | Buy |
1,032
+747
| +262% | +$37K | ﹤0.01% | 2425 |
|
|
2015
Q1 | $13.5K | Buy |
+285
| New | +$12.1K | ﹤0.01% | 2574 |
|
|
2014
Q4 | – | Sell |
-816
| Closed | -$28.9K | – | 3152 |
|
|
2014
Q3 | $28.9K | Buy |
816
+799
| +4,700% | +$28.2K | ﹤0.01% | 2917 |
|
|
2014
Q2 | $581 | Buy |
+17
| New | +$549 | ﹤0.01% | 3561 |
|
|
2014
Q1 | – | Sell |
-156
| Closed | -$5.5K | – | 3812 |
|
|
2013
Q4 | $5.5K | Buy |
+156
| New | +$5.11K | ﹤0.01% | 3040 |
|
Other funds holding USPH
BG
CCM
SAM
BNP Paribas Financial Markets's USPH Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its US Physical Therapy (USPH) stake by 38% in Q2 2026, selling an estimated $101K and leaving 2,451 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #4311.
BNP Paribas Financial Markets first reported a position in USPH in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.43M in Q3 2024. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- BNP Paribas Financial Markets held 2,451 shares of US Physical Therapy worth $168K as of Q2 2026.
- BNP Paribas Financial Markets sold 1,493 US Physical Therapy shares in Q2 2026, an estimated $101K.
- US Physical Therapy made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4311 holding.
- BNP Paribas Financial Markets first reported a position in US Physical Therapy in Q4 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's US Physical Therapy position peaked at $1.43M in Q3 2024.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.